Albumin fusion renders thioredoxin an effective anti-oxidative and anti-inflammatory agent for preventing cisplatin-induced nephrotoxicity

被引:64
作者
Kodama, Azusa [1 ]
Watanabe, Hiroshi [1 ,2 ]
Tanaka, Ryota [1 ]
Kondo, Masumi [3 ]
Victor Tuan Giam Chuang [4 ]
Wu, Qiong [3 ]
Endo, Masayuki [3 ]
Ishima, Yu [1 ,2 ]
Fukagawa, Masafumi [3 ]
Otagiri, Masaki [5 ,6 ]
Maruyama, Toru [1 ,2 ]
机构
[1] Kumamoto Univ, Sch Pharm, Grad Sch Pharmaceut Sci, Dept Biopharmaceut,Chuo Ku, Kumamoto 8620973, Japan
[2] Kumamoto Univ, Sch Pharm, Ctr Clin Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan
[3] Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, Hiratsuka, Kanagawa 25912, Japan
[4] Curtin Univ, Curtin Hlth Innovat Res Inst, Fac Hlth Sci, Sch Pharm, Perth, WA 6845, Australia
[5] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, Kumamoto 8600822, Japan
[6] Sojo Univ, DDS Res Inst, Nishi Ku, Kumamoto 8600822, Japan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2014年 / 1840卷 / 03期
基金
日本学术振兴会;
关键词
Acute kidney injury; Cisplatin nephrotoxicity; Oxidative stress; Inflammation; Thioredoxin; Fusion protein; ACUTE-RENAL-FAILURE; SERUM-ALBUMIN; LUNG INJURY; PROTEIN; RATS; RADICALS; ACTIVATION; APOPTOSIS; TRANSPORT; FIBROSIS;
D O I
10.1016/j.bbagen.2013.12.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Background: A strategy for preventing cisplatin nephrotoxicity due to enhanced oxidative stress and inflammatory response is highly desirable. Thioredoxin-1 (Trx), an endogenous redox-active protein, has a short retention time in the blood. A long acting form of Trx, human serum albumin-Trx (HSA-Trx), was produced by recombinant HSA fusion and its effectiveness in preventing cisplatin nephrotoxicity was examined. Methods: HSA-Trx was prepared in Pichia expression system. Cisplatin-induced nephropathy mouse model was established by a single administration of cisplatin. Results: Compared to saline, Trx or N-acetylcysteine, an intravenous administration of HSA-Tix attenuated the cisplatin-induced elevation in serum creatinine, blood urea nitrogen and urinary N-acetyl-beta-D-glucosaminidase along with the decrease in creatinine clearance. HSA-Trx caused a substantial reduction in the histological features of renal tubular injuries and the apoptosis-positive tubular cells. Changes in superoxide, 8-OHdG, glutathione and nitrotyrosine levels indicated that HSA-Trx significantly suppressed renal oxidative stress. HSA-Trx also suppressed the elevation of TNF-alpha, IL-1 beta and IL-6. Administered fluorescein isothiocyanate-labeled HSA-Trx was found partially localized in the proximal tubular cells whereas majority remained in the blood circulation. Specific cellular uptake and the scavenging of intracellular reactive oxygen species by HSA-Trx were observed in HK-2 cells. Conclusion: HSA-Trx could be a novel and effective approach for preventing cisplatin nephrotoxicity due to its prolonged anti-oxidative and anti-inflammatory action not only in extracellular compartment but also inside the proximal tubular cell. General signcance: We report the renoprotective effect of HSA-Trx against cisplatin nephrotoxicity. This work would enhance developing therapeutics against acute kidney injuries including cisplatin nephrotoxicity. (C) 2013.Elsevier B.V. All rights reserved.
引用
收藏
页码:1152 / 1162
页数:11
相关论文
共 41 条
[1]
N-acetylcysteine improves renal hemodynamics in rats with cisplatin-induced nephrotoxicity [J].
Abdelrahman, Aly M. ;
Al Salam, Suhail ;
AlMahruqi, Ahmed S. ;
Al Husseni, Ishaq S. ;
Mansour, Mohamed A. ;
Ali, Badreldin H. .
JOURNAL OF APPLIED TOXICOLOGY, 2010, 30 (01) :15-21
[2]
Redox properties of serum albumin [J].
Anraku, Makoto ;
Chuang, Victor Tuan Giam ;
Maruyama, Toru ;
Otagiri, Masaki .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2013, 1830 (12) :5465-5472
[3]
Cisplatin nephrotoxicity [J].
Arany, I ;
Safirstein, RL .
SEMINARS IN NEPHROLOGY, 2003, 23 (05) :460-464
[4]
Selective iNOS inhibition reduces renal damage induced by cisplatin [J].
Chirino, Yolanda I. ;
Trujillo, Joyce ;
Javier Sanchez-Gonzalez, Dolores ;
Maria Martinez-Martinez, Claudia ;
Cruz, Cristino ;
Bobadilla, Norma A. ;
Pedraza-Chaverri, Jose .
TOXICOLOGY LETTERS, 2008, 176 (01) :48-57
[5]
Chirino Yolanda I., 2004, BMC Pharmacology, V4, P20, DOI 10.1186/1471-2210-4-20
[6]
Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2 [J].
Ciarimboli, G ;
Ludwig, T ;
Lang, DF ;
Pavenstädt, H ;
Koepsell, H ;
Piechota, HJ ;
Haier, J ;
Jaehde, U ;
Zisowsky, J ;
Schlatter, E .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (06) :1477-1484
[7]
Thioredoxin, a singlet oxygen quencher and hydroxyl radical scavenger: Redox independent functions [J].
Das, KC ;
Das, CK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 277 (02) :443-447
[8]
Davis CA, 2001, J AM SOC NEPHROL, V12, P2683, DOI 10.1681/ASN.V12122683
[9]
Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels [J].
Dickey, DT ;
Wu, YJ ;
Muldoon, LL ;
Neuwelt, EA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (03) :1052-1058
[10]
Resveratrol attenuates cisplatin-induced nephrotoxicity in rats [J].
Do Amaral, Catia Lira ;
Francescato, Heloisa Della Coletta ;
Coimbra, Terezila Machado ;
Costa, Roberto Silva ;
Castania Darin, Joana D'arc ;
Greggi Antunes, Lusania Maria ;
Pires Bianchi, Maria De Lourdes .
ARCHIVES OF TOXICOLOGY, 2008, 82 (06) :363-370